BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24077234)

  • 21. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis.
    Mark M; Ghyselinck NB; Chambon P
    Annu Rev Pharmacol Toxicol; 2006; 46():451-80. PubMed ID: 16402912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
    Le Q; Dawson MI; Soprano DR; Soprano KJ
    Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoid receptors in human esophageal squamous cell carcinoma: retinoid X receptor as a potent prognostic factor.
    Fujishima F; Suzuki T; Nakamura Y; Taniyama Y; Ono K; Sugawara A; Miyazaki S; Moriya T; Sato A; Satomi S; Sasano H
    Pathol Int; 2011 Jul; 61(7):401-8. PubMed ID: 21707843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of retinoic acid receptors and their cognate ligands in reproduction in a context of triorganotin based endocrine disrupting chemicals.
    Macejova D; Toporova L; Brtko J
    Endocr Regul; 2016 Jul; 50(3):154-64. PubMed ID: 27560799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
    Tian K; Norris AW; Lin CL; Li E
    Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
    Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
    J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective retinoids and rexinoids in cancer therapy and chemoprevention.
    Zusi FC; Lorenzi MV; Vivat-Hannah V
    Drug Discov Today; 2002 Dec; 7(23):1165-74. PubMed ID: 12547017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.
    Desphande A; Xia G; Boerma LJ; Vines KK; Atigadda VR; Lobo-Ruppert S; Grubbs CJ; Moeinpour FL; Smith CD; Christov K; Brouillette WJ; Muccio DD
    Bioorg Med Chem; 2014 Jan; 22(1):178-85. PubMed ID: 24359708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive impact of retinoid X receptor-alpha-expression in renal-cell carcinoma.
    Buentig N; Stoerkel S; Richter E; Dallmann I; Reitz M; Atzpodien J
    Cancer Biother Radiopharm; 2004 Jun; 19(3):331-42. PubMed ID: 15285879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The retinoid signaling pathway: molecular and genetic analyses.
    Chambon P
    Semin Cell Biol; 1994 Apr; 5(2):115-25. PubMed ID: 8068884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nuclear receptor superfamily: a personal retrospect on the first two decades.
    Chambon P
    Mol Endocrinol; 2005 Jun; 19(6):1418-28. PubMed ID: 15914711
    [No Abstract]   [Full Text] [Related]  

  • 32. Retinoid receptors in inflammatory responses: a potential target for pharmacology.
    Kuenzli S; Tran C; Saurat JH
    Curr Drug Targets Inflamm Allergy; 2004 Dec; 3(4):355-60. PubMed ID: 15906483
    [No Abstract]   [Full Text] [Related]  

  • 33. Retinoid-interferon therapy of solid tumors.
    Lippman SM; Lotan R; Schleuniger U
    Int J Cancer; 1997 Feb; 70(4):481-3. PubMed ID: 9033661
    [No Abstract]   [Full Text] [Related]  

  • 34. Application of retinoids in the treatment of renal cell carcinoma--a futile effort?
    Schrader AJ; von Knobloch R; Heidenreich A; Buer J; Hofmann R
    Anticancer Drugs; 2004 Oct; 15(9):819-24. PubMed ID: 15457121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.
    Atigadda VR; Kashyap MP; Yang Z; Chattopadhyay D; Melo N; Sinha R; Belyaeva OV; Chou CF; Chang PL; Kedishvili NY; Grubbs CJ; Renfrow MB; Muccio DD; Elmets CA; Athar M
    J Med Chem; 2022 Nov; 65(21):14409-14423. PubMed ID: 36318154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant Triton tumour exhibits a complete expression pattern of nuclear retinoid and rexinoid receptor subtypes.
    Brtko J; Sejnová D; Ondková S; Macejová D
    Gen Physiol Biophys; 2009 Dec; 28(4):425-7. PubMed ID: 20097966
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyroid non-Hodgkin's lymphoma expression pattern of nuclear retinoid and rexinoid receptor subtypes.
    Brtko J; Macejova D; Galbavy S
    Gen Physiol Biophys; 2010 Dec; 29(4):411-3. PubMed ID: 21157005
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic syndrome and renal cell carcinoma.
    Zhang GM; Zhu Y; Ye DW
    World J Surg Oncol; 2014 Jul; 12():236. PubMed ID: 25069390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of retinoids in the therapy of renal disease.
    Wagner J
    Nephrol Dial Transplant; 2001 Mar; 16(3):441-4. PubMed ID: 11239012
    [No Abstract]   [Full Text] [Related]  

  • 40. Introduction to the nuclear receptor review series.
    Kelly DP
    Circ Res; 2010 May; 106(10):1557-8. PubMed ID: 20508199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.